News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,041 Results
Type
Article (41557)
Company Profile (259)
Press Release (665225)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (206327)
Career Advice (2037)
Deals (35727)
Drug Delivery (95)
Drug Development (81416)
Employer Resources (172)
FDA (16309)
Job Trends (15047)
News (348541)
Policy (32992)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2636)
Academic (1)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (50230)
ALS (88)
Alzheimer's disease (1390)
Antibody-drug conjugate (ADC) (124)
Approvals (16314)
Artificial intelligence (251)
Autoimmune disease (21)
Automation (16)
Bankruptcy (364)
Best Places to Work (11705)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (180)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (278)
Cancer (2252)
Cardiovascular disease (177)
Career advice (1704)
Career pathing (31)
CAR-T (149)
Cell therapy (419)
Cervical cancer (20)
Clinical research (66152)
Collaboration (838)
Compensation (523)
Complete response letters (19)
COVID-19 (2637)
CRISPR (40)
C-suite (239)
Cystic fibrosis (100)
Data (2188)
Decentralized trials (2)
Denatured (18)
Depression (41)
Diabetes (269)
Diagnostics (6537)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86983)
Editorial (35)
Employer branding (21)
Employer resources (146)
Events (113109)
Executive appointments (721)
FDA (17548)
Featured Employer (48)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (756)
Gene editing (105)
Generative AI (19)
Gene therapy (301)
GLP-1 (716)
Government (4461)
Grass and pollen (4)
Guidances (54)
Healthcare (18949)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (115)
Indications (29)
Infectious disease (2782)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (315)
IPO (16577)
IRA (40)
Job creations (3752)
Job search strategy (1449)
Kidney cancer (10)
Labor market (38)
Layoffs (468)
Leadership (17)
Legal (8027)
Liver cancer (75)
Lung cancer (323)
Lymphoma (152)
Machine learning (7)
Management (58)
Manufacturing (302)
MASH (67)
Medical device (13438)
Medtech (13443)
Mergers & acquisitions (19693)
Metabolic disorders (682)
Multiple sclerosis (79)
NASH (17)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1919)
NextGen: Class of 2025 (6550)
Non-profit (4536)
Northern California (2651)
Now hiring (39)
Obesity (363)
Opinion (207)
Ovarian cancer (75)
Pain (83)
Pancreatic cancer (83)
Parkinson's disease (149)
Partnered (21)
Patents (231)
Patient recruitment (108)
Peanut (47)
People (57917)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20620)
Phase II (29110)
Phase III (21698)
Pipeline (1179)
Policy (137)
Postmarket research (2584)
Preclinical (8851)
Press Release (67)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (247)
Rare diseases (379)
Real estate (6119)
Recruiting (65)
Regulatory (22569)
Reports (46)
Research institute (2382)
Resumes & cover letters (350)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (67)
Series A (131)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2290)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3620)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (37)
The Weekly (29)
United States (22992)
Vaccines (687)
Venture capitalists (41)
Weight loss (233)
Women's health (35)
Worklife (15)
Date
Today (246)
Last 7 days (903)
Last 30 days (2697)
Last 365 days (33045)
2025 (10468)
2024 (35421)
2023 (40333)
2022 (51425)
2021 (56013)
2020 (54490)
2019 (46957)
2018 (35320)
2017 (32506)
2016 (31973)
2015 (37999)
2014 (31857)
2013 (26978)
2012 (29100)
2011 (29779)
2010 (27816)
Location
Africa (734)
Alabama (53)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (38639)
Australia (6323)
California (6075)
Canada (2012)
China (521)
Colorado (267)
Connecticut (272)
Delaware (146)
Europe (83232)
Florida (901)
Georgia (204)
Idaho (57)
Illinois (530)
India (25)
Indiana (307)
Iowa (11)
Japan (157)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (890)
Massachusetts (4538)
Michigan (216)
Minnesota (392)
Mississippi (2)
Missouri (87)
Montana (30)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1715)
New Mexico (29)
New York (1733)
North Carolina (978)
North Dakota (8)
Northern California (2651)
Ohio (206)
Oklahoma (14)
Oregon (34)
Pennsylvania (1368)
Puerto Rico (12)
Rhode Island (33)
South America (1126)
South Carolina (22)
South Dakota (1)
Southern California (2290)
Tennessee (101)
Texas (902)
Utah (182)
Virginia (143)
Washington D.C. (61)
Washington State (552)
West Virginia (3)
Wisconsin (54)
707,041 Results for "asymchem laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Asymchem Secures Former Pfizer Sandwich, UK, Development and API Pilot Plant Manufacturing Facilities
Asymchem Laboratories Co., Ltd. announced that it will operate the former Pfizer U.K. small molecule API pilot plant and part of the development laboratories through a new lease agreement between Asymchem and Discovery Park, establishing Asymchem’s first manufacturing footprint in Europe.
May 21, 2024
·
3 min read
Business
Asymchem Appoints Dr. Cheng Yi Chen as CTO of Small-Molecule Sector
In line with Asymchem’s continuous strategic layout and development, the organization has welcomed Dr. Cheng Yi Chen as a senior executive.
June 26, 2024
·
2 min read
Business
Asymchem Welcomes Franck Mevellec as Senior Director, Business Development
Asymchem, a leading global CDMO, is excited to announce the appointment of Franck Mevellec as senior director, business development.
May 29, 2024
·
1 min read
Press Releases
Asymchem’s Fully Automated Peptide Production Lines Set New Benchmarks as Large-Scale Capacity Continues to Grow
November 13, 2024
·
2 min read
Business
Asymchem Announces Opening of R&D site near Boston, Massachusetts
Asymchem Laboratories Co., Ltd. announced their opening of a new site in Woburn, Massachusetts – Asymchem Boston, a wholly owned subsidiary of Asymchem Group, as an important step to expand Asymchem’s global footprint.
December 19, 2022
·
2 min read
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Press Releases
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025
January 17, 2025
·
1 min read
Deals
Asymchem Acquires Snapdragon Chemistry
Asymchem Laboratories (Tianjin) Co., Ltd. (stock code: 002821.SZ/6821.HK) (“Asymchem”), a leading CDMO serving the global pharmaceutical and biotech industry, today announced its agreement to acquire Snapdragon Chemistry, Inc.
February 11, 2022
·
3 min read
Eurofins CDMO Alphora Inc. Announces the Launch of Expanded Drug Product Analytical Laboratory
Eurofins CDMO Alphora Inc., a global Contract Development & Manufacturing Organization and part of the international network of Eurofins laboratories, is pleased to announce a significant expansion of its Drug Product Analytical Services Laboratory, increasing its footprint three-fold.
May 29, 2024
·
2 min read
Business
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results
Mesa Laboratories, Inc. will not issue its 2024 financial results for the fourth quarter and the fiscal year ending March 31, 2024 as previously communicated.
May 31, 2024
·
1 min read
1 of 70,705
Next
